Epigenetic drug discovery and tools
 

Drug Discovery

CellCentric is a drug discovery company developing small molecule inhibitors for cancer.

 

CellCentric is focused on the most aggressive form of prostate cancer, for which there are few long term treatments.  The company is developing inhibitors to two enzymes that modulate the androgen receptor pathway, and that have the potential to overcome many of the resistance mechanisms seen with existing drugs.